In this article, we will take a look at some of the best US stocks under $10 to invest in.
Everyone seeks a stock that has good upside potential, but a stock that is cheap and has good prospects – that’s what a steal deal looks like. From leading investors to top analysts, the financial experts have stressed one thing: a cheap price doesn’t always imply the stock’s value.
In recent times, investors have shifted their focus from high-flying tech stocks to more valuable, mispriced companies, aiming to invest in genuine bargains. As Warren Buffett says,
“Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.”
For instance, a study by Josef Lakonishok, Andrei Shleifer, and Robert Vishny in 1994 highlights that value stocks tend to outperform glamour stocks by substantial margins. Thus, a smart investor is the one who acquires stocks when nobody wants them.
Our Methodology
In compiling a list of the 8 best US stocks under $10 to invest in, we have selected stocks that are favorites among investors. These stocks have positive upside potential and are recommended by research firms. The upside potential is calculated using the one-year price targets by Yahoo Finance and then ranked in ascending order.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
8. Definitive Healthcare Corp. (NASDAQ:DH)
Upside potential as of August 16, 2025: 17.31%
BofA Securities has reaffirmed its Buy rating on Definitive Healthcare Corp. (NASDAQ:DH), while maintaining a price target of $4.50, implying a surge of 16.3%. This move comes as the company reports revenue and EBITDA above the research firm’s estimates and consensus forecasts.
In its latest earnings call, Definitive Healthcare Corp. (NASDAQ:DH) has raised full-year revenue guidance to $237-$240 million owing to better retention. This signals the company’s focus on streamlining its sales force. The management also announced the addition of 12 new enterprise clients within the quarter.
The company’s future looks promising, with analysts emphasizing retention rates, renewal trends, and the impact of operational changes. With strong initiatives in mind, Definitive Healthcare Corp. (NASDAQ:DH) is poised for growth.
Definitive Healthcare Corp. (NASDAQ:DH), headquartered in Massachusetts, is a provider of a SaaS healthcare commercial intelligence platform. Founded in 2011, the company has a well-diversified clientele in the biopharmaceutical, healthcare, and technology industries.
7. Evolv Technologies Holdings, Inc. (NASDAQ:EVLV)
Upside potential as of August 16, 2025: 22.58%
Cantor Fitzgerald analysts have increased the price target on Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) to $9, up from $7, with an unchanged Overweight rating. This move follows the company’s strong quarterly performance, delivering a 29% year-over-year revenue growth.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) appears to be in a strong position under new management, outperforming its competitors and transitioning smoothly to a small-cap company with an equally promising future. Having said that, the stock has posted a return of 115% compared to the 16.35% one-year return of the S&P 500 (^GSPC).
The company’s commitment to building a durable and high-growth business with predictable results is what sets it apart from the others. Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) also announced upward guidance during its latest earnings call. With such optimism surrounding the company, there’s no doubt that the investors are gravitating towards the stock.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), founded in 2013, is a Massachusetts-based provider of AI weapons detection that aids in artificial intelligence (AI)-based weapons detection. The core offerings of the company include Evolv Express, Evolv Insights Analytics Application, and Evolv eXpedite.